Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for methamphetamine-related neuropsychological disorders
IRCT2016102630510N1Phase 4Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of minocycline in Methamphetamine-induced neurocognitive disorder and methamphetamine use disorder (MUD), sponsored by Iran University of Medical Sciences. Started Dec 2016; status: completed.
02
Drugs
minocycline
03
Conditions
Methamphetamine-induced neurocognitive disordermethamphetamine use disorder (MUD)
Beyond the preview
Go deeper on IRCT2016102630510N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016102630510N1.